Chris J. Beltran

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Stereotactic ablative radiotherapy is being increasingly adopted in the treatment of lung tumors. The use of proton beam therapy can further reduce dose to normal structures. However, uncertainty exists in proton-based treatment plans, including range uncertainties, large sensitivity to position uncertainty, and calculation of dose deposition in(More)
  • 1